Is Avastin on PBS in Australia?

The bevacizumab originator (Avastin) was deleted from the PBS on 1 June 2021. The manufacturer decided to take Avastin off the market in Australia from 30 June 2021 for the 100mg/4mL dose and from 3 December 2021 for the 400mg/16mL dose.

What is the purpose of the Pharmaceutical Benefits Scheme?

Some prescription medicines can cost a lot of money. The Pharmaceutical Benefits Scheme (PBS) can lower the cost. Under the PBS, the Australian Government subsidises the cost of medicine for most medical conditions. This means Australians can use a wide range of medicines without paying full price for them.

What is the Pharmaceutical Benefits Scheme Australia?

The Pharmaceutical Benefits Scheme (PBS) is an Australian Government program that benefits you and all Australians by subsidising medicines to make them more affordable. This means you can get access to lifesaving medicines when you need them most. The PBS is governed by the National Health Act 1953.

Is bevacizumab on the PBS?

Mvasi®, a biosimilar brand of bevacizumab, was listed on the PBS from 1 June 2021, as an unrestricted PBS benefit, which means all Australians who receive a prescription from their treating doctor for bevacizumab are able to access this medicine at the subsidised PBS price.

Who is eligible for Pharmaceutical Benefits Scheme?

Who is eligible for the PBS? The Scheme is available to all Australian residents who hold a current Medicare card. Overseas visitors from countries with which Australia has a Reciprocal Health Care Agreement (RHCA) are also eligible to access the Scheme.

How do I get a pharmaceutical benefit scheme?

To apply, complete the PBS/RPBS Safety Net prescription record form and application for a Safety Net card form. Type your details into page one of the form, then print out both pages. Hand both pages to your pharmacist. They will give you a card.

Is Avastin still used?

Avastin, which had been used to treat breast cancer, is no longer approved by the FDA for this purpose, because the risks of the drug outweigh the benefits.